Roflumilast Foam, 0.3%, for Psoriasis of the Scalp and Body: The ARRECTOR Phase 3 Randomized Clinical Trial.
Saved in:
| Title: | Roflumilast Foam, 0.3%, for Psoriasis of the Scalp and Body: The ARRECTOR Phase 3 Randomized Clinical Trial. |
|---|---|
| Authors: | Gooderham MJ; SKiN Centre for Dermatology, Peterborough, Ontario, Canada.; Probity Medical Research, Peterborough, Ontario, Canada.; Department of Medicine, Queen's University, Peterborough, Ontario, Canada., Alonso-Llamazares J; Driven Research, Coral Gables, Florida., Bagel J; Psoriasis Treatment Center of Central New Jersey, East Windsor, New Jersey., Bhatia N; Therapeutics Clinical Research, San Diego, California., Bukhalo M; Arlington Dermatology, Rolling Meadows, Illinois., DuBois J; DermResearch, Austin, Texas., Ferris LK; Department of Dermatology, University of Pittsburgh, Pittsburgh, Pennsylvania., Green L; George Washington University School of Medicine, Rockville, Maryland., Kircik LH; Waldman Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York.; Department of Dermatology, Indiana Medical Center, Indianapolis.; Physicians Skin Care, Louisville, Kentucky.; Skin Sciences, Louisville, Kentucky., Lockshin B; DermAssociates, Rockville, Maryland., Loo WJ; DermEffects, London, Ontario, Canada.; Western University, London, Ontario, Canada.; Probity Medical Research, London, Ontario, Canada., Papp KA; Probity Medical Research, Waterloo, Ontario, Canada.; Division of Dermatology, Temerty Faculty of Medicine, University of Toronto, Ontario, Canada.; Alliance Clinical Trials, Waterloo, Ontario, Canada., Soung J; Southern California Dermatology, Santa Ana., Seal MS; Arcutis Biotherapeutics, Westlake Village, California., Snyder S; Arcutis Biotherapeutics, Westlake Village, California., Kato S; Arcutis Biotherapeutics, Westlake Village, California., Krupa D; Arcutis Biotherapeutics, Westlake Village, California., Burnett P; Arcutis Biotherapeutics, Westlake Village, California., Berk DR; Arcutis Biotherapeutics, Westlake Village, California., Chu DH; Arcutis Biotherapeutics, Westlake Village, California. |
| Source: | JAMA dermatology [JAMA Dermatol] 2025 Jul 01; Vol. 161 (7), pp. 698-706. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101589530 Publication Model: Print Cited Medium: Internet ISSN: 2168-6084 (Electronic) Linking ISSN: 21686068 NLM ISO Abbreviation: JAMA Dermatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2168-6084 |
|---|---|
| DOI: | 10.1001/jamadermatol.2025.1136 |
